macrophagic myofasciitis

macrophagic myofasciitis

A recently-described apparently new disease featuring fever, muscle and joint pain, muscle and general weakness and infiltration of the tissues around the muscles by sheets of large, finely-granular MACROPHAGES. The muscle fibres, themselves are minimally affected. The microscopic appearances are unlike those of any previous muscle or fascial disorder. The condition appears to respond to treatment with various combinations of antibiotics and steroids. It was first described by the French physicians and histopathologists Professor R.K. Gerardi, M. Coquet, F-J Authier, P. Laforêt,L. Bélec, D. Figarelle-Branger, J-M Mussini, J-F Pellissier and M. Fardeau.
References in periodicals archive ?
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
Central nervous system disease in patients with macrophagic myofasciitis.
Arthritis, type 1 diabetes, multiple sclerosis, lupus, macrophagic myofasciitis, and autism spectrum disorders are among the autoimmune/ inflammatory conditions linked to aluminum-adjuvanted vaccines.
A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.
Macrophagic myofasciitis was first reported in 1998.
Two years earlier, he had been diagnosed with macrophagic myofasciitis.
These vocal fold deposits have not been previously described in patients with macrophagic myofasciitis.
One-third of patients with macrophagic myofasciitis develop an autoimmune disease.
The etiology of macrophagic myofasciitis remained obscure until 2001.
Aluminium phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis.
The researchers call the condition macrophagic myofasciitis (MMF).
A June 2006 muscle biopsy revealed the presence of aluminum, confirming a diagnosis of macrophagic myofasciitis.